Pace Logo

Life Sciences

Frank Tagliaferri, Pace Life Sciences

Addressing the Complexity of Modern Therapeutics – Dr. Frank Tagliaferri, Pace® Life Sciences

Life Sciences /

The modern therapeutic landscape is defined by an ever-growing portfolio of complex drug products – from biologics and gene therapies to mRNA-based vaccines and monoclonal antibodies. These therapies, which often involve intricate fomulations and require advanced sterile processing, have fundamentally altered the demands placed on fill-finish operations. Frank Tagliaferri, chief scientific officer at Pace® Life […]

Addressing the Complexity of Modern Therapeutics – Dr. Frank Tagliaferri, Pace® Life Sciences Read More »

Pace Life Sciences Scientist working in laboratory.

Pace® Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025

Life Sciences /

Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more. Minneapolis, MN – January 10, 2025 – Pace® Life Sciences, LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of Pace®, a Science and Technology Company, today announced significant growth plans for two of the company’s locations. Pace® Life

Pace® Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025 Read More »

Pace Life Sciences Research Triangle Park

Pace® Life Sciences Expands Capacity and Capability with Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park

Life Sciences /

Company broadens service offerings and strengthens network by purchasing Catalent’s Center-of-Excellence for Small Molecule Analytical Services facility in North Carolina Minneapolis, MN – September [26], 2024 – Pace® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that it has acquired from

Pace® Life Sciences Expands Capacity and Capability with Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park Read More »

Frank Tagliaferri, Pace Life Sciences

Exploring Innovative Means for Biologics Delivery – Dr. Frank Tagliaferri, Pace® Life Sciences

Life Sciences /

Alternative delivery methods for biologics continues to be explored that offer less invasive, less painful administration. Despite their track record of demonstrating significant therapeutic efficacy, biologics still face daunting challenges in their drug delivery. Biologics such as monoclonal antibodies (mAbs) and some vaccines are largely administered via injection or by infusion. These methods can often

Exploring Innovative Means for Biologics Delivery – Dr. Frank Tagliaferri, Pace® Life Sciences Read More »

Pace Life Sciences Oakdale Location.

Pace® Life Sciences Announces Compliant US FDA Inspection of Operations in Oakdale, MN

Life Sciences /

Proven track record of consistent high quality confirmed at Pace® Life Sciences headquarters MINNEAPOLIS, MN., July 25, 2024 (NEWSWIRE.COM): Pace® Life Sciences, a full-service FDA-registered GMP Analytical Testing laboratory and contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today a successful inspection from The Food &

Pace® Life Sciences Announces Compliant US FDA Inspection of Operations in Oakdale, MN Read More »

Dean Bornilla, Pace Life Sciences.

Pace® Life Sciences Division Names Dean Bornilla as Head of Commercial

Life Sciences /

Bornilla brings over 25 years of commercial pharmaceutical experience to Pace® MINNEAPOLIS (July 23, 2024) – Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dean Bornilla has been named Head of Commercial reporting to Dawn Von Rohr, President, Pace® Life

Pace® Life Sciences Division Names Dean Bornilla as Head of Commercial Read More »

Pace Life Sciences San German Laboratory

Pace® Life Sciences Announces Successful Outcomes Following US FDA Inspection of Operations in San German, Puerto Rico

Life Sciences /

Long-standing reputation for robust quality is confirmed as company enters 2024  SAN GERMAN, PR., March 28, 2024 (NEWSWIRE.COM): Pace® Life Sciences, LLC, a full-service FDA-registered central laboratory and contract development and manufacturing organization (CDMO) announced the receipt of an overall positive review from The Food & Drug Administration (FDA), following a three-day general inspection of

Pace® Life Sciences Announces Successful Outcomes Following US FDA Inspection of Operations in San German, Puerto Rico Read More »

Pace Life Sciences Scientist Working in Laboratory

Pace® Life Sciences Acquires New Jersey Laboratory from Curia

Life Sciences /

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network Minneapolis, MN [March 14, 2024] Pace® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO), announced today that it has acquired the Lebanon, New Jersey laboratory facility (formerly Whitehouse Analytical Laboratories) from Curia, a global contract research, development, and manufacturing (CDMO) company.

Pace® Life Sciences Acquires New Jersey Laboratory from Curia Read More »

Dawn Von Rohr, Pace Life Sciences

Pace® Life Sciences Appoints Dawn Von Rohr as Division President

Life Sciences /

Von Rohr brings over 25 years of experience to company Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dawn Von Rohr has been named Division President. Von Rohr will be responsible for driving growth and continued innovations within the Pace®

Pace® Life Sciences Appoints Dawn Von Rohr as Division President Read More »